跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TARO-RAMIPRIL HCTZ - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TARO-RAMIPRIL HCTZ
Authorized
STANDARD
TARO-RAMIPRIL HCTZ
sun pharma canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
25236ad0ffefcbe2
Company
sun pharma canada inc
Type
Standard
Approval Details
Approval Id
25236ad0ffefcbe2
Drug Approval Canada Name
TARO-RAMIPRIL HCTZ
Product Name
TARO-RAMIPRIL HCTZ
Status
Marketed
Status Date
2023-12-12
Original Market Date
2017-12-05
Din
02449455
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
40:28.20
Atc Original
C09BA05 RAMIPRIL AND DIURETICS
Atc Name
c 09 ba 05
Aig Number
0251649003
Company Name
sun pharma canada inc
Company Address
126 East Drive, Brampton, Ontario, Canada, L6T 1C1
Active Ingredients
HYDROCHLOROTHIAZIDE
12.5 MG
RAMIPRIL
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
25236ad0ffefcbe2
Type
Standard
Back to Health Canada Approvals